Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / SNY - Kyowa Kirin: Agreement With Amgen Points To A Blockbuster Drug

SNY - Kyowa Kirin: Agreement With Amgen Points To A Blockbuster Drug

Sanofi
  • Early indications show that Kyowa Kirin has a blockbuster drug with KHK4083, a treatment for severe atopic dermatitis (eczema).
  • Phase 2 trials have shown encouraging results and the agreement to jointly develop and commercialize the drug with Amgen is a positive signal.
  • With both short and longer term earnings visibility and no major patent expirations until mid-2030, we are bullish on the shares.

For further details see:

Kyowa Kirin: Agreement With Amgen Points To A Blockbuster Drug
Stock Information
Company Name: Sanofi
Stock Symbol: SNY
Market: NASDAQ
Website: sanofi.com
Menu
SNY SNY Quote SNY Short SNY News SNY Articles SNY Message Board
Get SNY Alerts

News, Short Squeeze, Breakout and More Instantly...